| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/23/2004 | CN1507449A 1-oxa-3,9-diaza-spiro [5,5] undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 06/23/2004 | CN1507448A N-But-3-Enyl norbuprenophine and its use as analgesic |
| 06/23/2004 | CN1507447A Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 06/23/2004 | CN1507444A 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity |
| 06/23/2004 | CN1507442A Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 06/23/2004 | CN1507437A Aralkylpiperazines with serotonin 5-HTIA activity |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/23/2004 | CN1507357A Method and compositions for enhanced delivery of bioactive molecules |
| 06/23/2004 | CN1507351A Treatment of ADHD |
| 06/23/2004 | CN1506373A Composition, extraction process and use of total triterpene sapogenin extracted from bamboo |
| 06/23/2004 | CN1506116A Process for preparing degradable polymer and medical composition containing the said polymer and use thereof |
| 06/23/2004 | CN1506111A Production process of freeze dried scorpion venom polypeptide powder prepn |
| 06/23/2004 | CN1506056A Cell growth regulating factor R and its prepn process |
| 06/23/2004 | CN1154656C Memory-improving peptides and their application |
| 06/23/2004 | CN1154655C K receptor opioid peptides |
| 06/23/2004 | CN1154646C Benzisozazoles and phenones as alpha antagonist |
| 06/23/2004 | CN1154635C Novel compounds with analgesic effect |
| 06/23/2004 | CN1154508C Stimulation of host defence mechanisms against viral challenges |
| 06/23/2004 | CN1154507C Inhibition of binding of Hox and homeodomain containing proteins and uses thereof |
| 06/23/2004 | CN1154496C Application of Odanpine of fluoxetine in medicine for treatment of refractory depression |
| 06/23/2004 | CN1154495C Use of mirtazapine for treating sleep apneas |
| 06/23/2004 | CN1154490C Celecoxib compositions |
| 06/23/2004 | CN1154489C Heterocyclic vinylethers against neurological disorders |
| 06/23/2004 | CN1154485C Use of a specific antagonist of 5HTz receptors for preparing medicine useful for treating sleep-disordered breathing |
| 06/22/2004 | US6753412 Human Eag2 |
| 06/22/2004 | US6753349 Solvent-free salt formation by reaction with alkali/alkaline earth carbonate and/or bicarbonate; continuous removal of water and carbon dioxide |
| 06/22/2004 | US6753340 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents |
| 06/22/2004 | US6753336 Melanin concentrating hormone receptor ligands |
| 06/22/2004 | US6753335 Delta agonists for nervous system pain |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/22/2004 | US6753327 Neurodegenerative disorder or neuronal damage treatment; inhibitors of calpain or cathepsin cysteine proteases; antiischemic agents; reperfusion injuries |
| 06/22/2004 | US6753325 Comprises vitamin d3 for controlling cell differentiation and/or cell proliferation |
| 06/22/2004 | US6752997 Process for preparing non-hygroscopic sodium valproate composition |
| 06/22/2004 | CA2192596C 4-(6-fluoro-1,2-benzisoxazolyl)-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety |
| 06/22/2004 | CA2104793C Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5 alpha-reductase inhibitor and an antiandrogen |
| 06/22/2004 | CA2095523C Composition comprising a tramadol material and acetaminophen and its use |
| 06/19/2004 | CA2452946A1 Detection and diagnosis of transmissible spongiform encephalopathies |
| 06/17/2004 | WO2004050913A1 Treatment of huntington’s disease with epa |
| 06/17/2004 | WO2004050876A1 A recombinant adenovirus relating gene vaccine used to therapy and prevent alzheimers disease, and use thereof |
| 06/17/2004 | WO2004050865A1 Method for culturing neural stem cells using hepatocyte growth factor |
| 06/17/2004 | WO2004050690A1 NOVEL χ-CONOTOXIN PEPTIDES (-I) |
| 06/17/2004 | WO2004050688A1 NOVEL χ-CONOTOXIN PEPTIDES (-II) |
| 06/17/2004 | WO2004050656A1 1,3-dihydroimidazole fused-ring compound |
| 06/17/2004 | WO2004050655A1 Polymorphic forms of ziprasidone and its hydrochloride |
| 06/17/2004 | WO2004050631A1 Substituted dihydrophenanthridinesul fonamides |
| 06/17/2004 | WO2004050630A1 The use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence |
| 06/17/2004 | WO2004050629A2 The use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence |
| 06/17/2004 | WO2004050628A1 The use of 4-phenyl-substituted tetrahydroisoquinolines in the treatment of pain, migraine headaches and urinary incontinence |
| 06/17/2004 | WO2004050627A1 A quinoline amide derivative as agent against disorders of the cns |
| 06/17/2004 | WO2004050626A1 A quinoline amide derivative as agent against disorders of the cns |
| 06/17/2004 | WO2004050619A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 06/17/2004 | WO2004050612A1 S-substituted n-1-[(hetero)aryl]alkyl-n′-[(hetero)aryl] alkylysothiocarbamides, method for the production thereof, physiologically active s-substituted n-1-[(hetero)aryl]alkyl-n′-[(hetero)aryl]alkylysothiocarbamides, a pharmaceutical compound and curing method |
| 06/17/2004 | WO2004050609A1 Substituted ureas and carbamates |
| 06/17/2004 | WO2004050120A2 Treatment of prion-induced diseases by administration fo anti-prion antibodies |
| 06/17/2004 | WO2004050116A1 Protease inhibitor |
| 06/17/2004 | WO2004050114A1 Novel agent for improving neurotransmission failure |
| 06/17/2004 | WO2004050113A1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE |
| 06/17/2004 | WO2004050110A1 Medicinal composition |
| 06/17/2004 | WO2004050104A1 Herbal product of salvia officinalis |
| 06/17/2004 | WO2004050091A1 Phosphodiesterase 10a inhibitors |
| 06/17/2004 | WO2004050088A1 Jnk inhibitor |
| 06/17/2004 | WO2004050086A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 06/17/2004 | WO2004050085A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
| 06/17/2004 | WO2004050083A1 Iontophoretic delivery of rotigotine for the treatment of parkinson's disease |
| 06/17/2004 | WO2004050019A2 Method and compositions for treating anxiety |
| 06/17/2004 | WO2004039371A3 Compositions of cyclooxygenase-2 selective inhibitors and nmda receptor antagonists for the treatment or prevention of neuropathic pain |
| 06/17/2004 | WO2004038411A3 Diagnostic and therapeutic use of ensadin-0289 gene and protein for neurodegenerative diseases |
| 06/17/2004 | WO2004037769A3 Cycloalkylamides and their therapeutic use as antiepileptic and anticonvulsant |
| 06/17/2004 | WO2004035534A3 Novel compounds having a dopaminergic and/or serotoninergic activity |
| 06/17/2004 | WO2004029204A3 Substituted pyrimidines |
| 06/17/2004 | WO2004026229A3 Pyrazolo[1,5-a]pyrimidines compounds as cyclin dependent kinase inhibitors |
| 06/17/2004 | WO2004014316A3 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 06/17/2004 | WO2004012651A3 Composition for heart disease, method to prepare same and uses thereof |
| 06/17/2004 | WO2004003164A3 Methods of organ regeneration |
| 06/17/2004 | WO2003106660A3 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/17/2004 | WO2003105781A3 Ophthalmic compositions for treating ocular hypertension |
| 06/17/2004 | WO2003102138A3 Elongase genes and uses thereof |
| 06/17/2004 | WO2003055879A3 Tropane derivative, chelation product comprising this tropane derivative and a metal or a metal complex, and radiopharmaceutical |
| 06/17/2004 | WO2003053997A3 Methods of increasing endogenous erythropoietin (epo) |
| 06/17/2004 | WO2003053334A3 Compositions and methods for the diagnosis and treatment of tumor |
| 06/17/2004 | WO2003051380A3 Compositions containeing curcuma extracts for the treatment of neurocerebrovascular disorders |
| 06/17/2004 | WO2003037308A8 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 06/17/2004 | WO2003026566A3 Atlastin |
| 06/17/2004 | WO2003026564A9 Pharmaceutical compositions for the treatment of urinary disorders |
| 06/17/2004 | WO2003024972A8 New oripavine derivatives and their uses as medicines |
| 06/17/2004 | WO2003000018A3 Dopamine agonist formulations for enhanced central nervous system delivery |
| 06/17/2004 | US20040116707 4-Pyrrolidino-phenyl-benzyl ether derivatives |
| 06/17/2004 | US20040116706 Therapeutic ureas |
| 06/17/2004 | US20040116703 Central nervous system disorders, nicotinic acetylcholine receptors; endocrine diseases; antiinflammatory agents; analgesics; drug dependency; skin disorders; Alzheimer's and Parkinson's disease |
| 06/17/2004 | US20040116698 6-Substituted pyrido-pyrimidines |
| 06/17/2004 | US20040116697 Novel compounds |
| 06/17/2004 | US20040116695 2-Mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 06/17/2004 | US20040116672 Human sel-10 polypeptides and polynucleotides that encode them |
| 06/17/2004 | US20040116656 Memory-enhancing peptides and the use thereof |
| 06/17/2004 | US20040116534 Methods of treating and preventing narcolepsy using enantiomerically pure (s)-didesmethylsibutramine |
| 06/17/2004 | US20040116532 Isomers of 2-[(diphenylmethyl)sulfinyl] acetamide, including excipients such as diluents, binders or lubricants, used for prophylaxis of attention deficit disorder |
| 06/17/2004 | US20040116527 Agents against stress-induced diseases |
| 06/17/2004 | US20040116516 Pharmaceutical composition |
| 06/17/2004 | US20040116507 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/17/2004 | US20040116505 By administering a pyrrolidone compound such as aniracetam, piracetam, oxiracetam, pramiracetam, nefiracetam, nebracetam, fasoracetam, or levetiracetam; Tourette's syndrome, parkinson's disease for example |